Conversely, blocking the IL-6/JAK2/STAT3 pathway can inhibit the progression of precancerous vocal cord (oral) leukoplakia and delay the occurrence of head and neck squamous cell carcinoma (HNSCC) tumors [48]. This evidence concerns the gene JAK2 and head and neck squamous cell carcinoma.